These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 4790710)

  • 1. Cell-mediated and humoral immune reactions to human tumours.
    Baldwin RW; Embleton MJ; Jones JS; Langman MJ
    Int J Cancer; 1973 Jul; 12(1):73-83. PubMed ID: 4790710
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-mediated cytotoxicity against human bladder cancer.
    Bloom ET; Ossorio RC; Brosman SA
    Int J Cancer; 1974 Sep; 14(3):326-34. PubMed ID: 4477556
    [No Abstract]   [Full Text] [Related]  

  • 3. Demonstration of cell-mediated and blocking immune responses to tumor antigens in cancer patients with the colony-inhibition-in-gel test.
    Cummings FJ; Heppner GH; Stolbach L; Calabresi P
    Isr J Med Sci; 1973 Mar; 9(3):308-16. PubMed ID: 4710038
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on specificity of cell-mediated immunity to human tumors.
    Takasugi M; Mickey MR; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor-specific cellular immunity.
    Cohen AM; Burdick JF; Ketcham AS
    J Surg Res; 1971 Aug; 11(8):421-31. PubMed ID: 4936302
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity.
    Hellström I; Hellström KE; Sjögren HO; Warner GA
    Int J Cancer; 1971 Sep; 8(2):185-91. PubMed ID: 4332366
    [No Abstract]   [Full Text] [Related]  

  • 7. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.
    Hellström I; Sjögren HO; Warner G; Hellström KE
    Int J Cancer; 1971 Mar; 7(2):226-37. PubMed ID: 5104167
    [No Abstract]   [Full Text] [Related]  

  • 8. Humoral cytotoxicity in melanoma patients and its correlation with the extent and course of the disease.
    Canevari S; Fossati G; Della Porta G; Balzarini GP
    Int J Cancer; 1975 Nov; 16(5):722-9. PubMed ID: 1184240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro cytotoxicity studies in bladder and renal cell cancer.
    Elhilali MM; Nayak SK
    Urology; 1976 May; 7(5):488-91. PubMed ID: 1274005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractions.
    Baldwin RW; Embleton MJ; Price MR
    Int J Cancer; 1973 Jul; 12(1):84-92. PubMed ID: 4790711
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-mediated immunity to tumor antigens in patients with renal cell carcinoma.
    Cummings KB; Peter JB; Kaufman JJ
    J Urol; 1973 Jul; 110(1):31-5. PubMed ID: 4713354
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro cell-mediated immune reactions of melanoma and colorectal carcinoma patients demonstrated by long-term 51chromium assays.
    Steele G; Sjögren HO; Stadenberg I
    Int J Cancer; 1976 Jan; 17(1):27-39. PubMed ID: 1248900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection in colorectal carcinoma patients of antibody cytotoxic to established cell strains derived from carcinoma of the human colon and rectum.
    Schultz RM; Woods WA; Chirigos MA
    Int J Cancer; 1975 Jul; 16(1):16-23. PubMed ID: 51831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte mediated cytotoxicity to tumor antigens.
    Hellström I; Hellström KE
    Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
    [No Abstract]   [Full Text] [Related]  

  • 15. Significance of tumour associated antigens on human colonic carcinomata.
    Embleton MJ
    Br J Cancer Suppl; 1973 Aug; 1():142-52. PubMed ID: 4804277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a new oncofoetal antigen associated with several types of human carcinomas.
    Fritsché R; Mach J
    Nature; 1975 Dec; 258(5537):734-7. PubMed ID: 1207757
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic testing as a guide to cancer management.
    Wanebo HJ
    Surg Clin North Am; 1979 Apr; 59(2):323-47. PubMed ID: 375447
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell-mediated immunity and specific serum factors in human cancer: the leukocyte adherence inhibition test.
    Maluish A; Halliday WJ
    J Natl Cancer Inst; 1974 May; 52(5):1415-20. PubMed ID: 4831432
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological studies of women with primary breast carcinoma.
    Jeejeebhoy HF
    Int J Cancer; 1975 Jun; 15(6):867-78. PubMed ID: 1150343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediation of cytotoxic immune responses against human tumor-associated antigens by allogeneic immune RNA.
    Kern DH; Fritze D; Schick PM; Chow N; Pilch YH
    J Natl Cancer Inst; 1976 Jul; 57(1):105-9. PubMed ID: 1003493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.